1249 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1201 | 12008682 | Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus. | 2002 Apr | 5 |
1202 | 12022906 | Insulin glargine: a new basal insulin. | 2002 Jun | 15 |
1203 | 12032121 | Use of insulin glargine during pregnancy in a type 1 diabetic woman. | 2002 Jun | 1 |
1204 | 12060061 | No evidence for accumulation of insulin glargine (LANTUS): a multiple injection study in patients with Type 1 diabetes. | 2002 Jun | 7 |
1205 | 12145255 | Twenty-four hour action of insulin glargine (Lantus) may be too short for once-daily dosing: a case report. | 2002 Aug | 1 |
1206 | 12150359 | Insulin therapy in type 2 diabetes. | 2002 Jul-Aug | 2 |
1207 | 12166545 | Insulin glargine (Lantus). | 2002 Jul-Aug | 17 |
1208 | 12166610 | Clinical strategies for controlling peaks and valleys: type 1 diabetes. | 2002 Jul | 3 |
1209 | 12324986 | Insulin therapy in Europe. | 2002 Sep-Oct | 2 |
1210 | 12324987 | An overview of insulin glargine. | 2002 Sep-Oct | 7 |
1211 | 12324990 | Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus. | 2002 Sep-Oct | 4 |
1212 | 12351503 | Insulin glargine in continuous enteric tube feeding. | 2002 Oct | 1 |
1213 | 12391389 | Insulin glargine: a new basal insulin analogue. | 2002 Nov | 2 |
1214 | 15765621 | Spotlight on insulin glargine in type 1 and 2 diabetes mellitus. | 2002 | 12 |
1215 | 11213905 | Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes. | 2001 Feb | 2 |
1216 | 11315821 | Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. | 2001 Apr | 4 |
1217 | 11367996 | [Delayed action insulins. What is the value of insulin glargine in general practice?]. | 2001 Apr 19 | 1 |
1218 | 11402927 | [Clinical effects and pharmacodynamics of insulin analogs lispro, aspart and glargin]. | 2001 May 18 | 1 |
1219 | 11460580 | Physiological insulin replacement in type 1 diabetes mellitus. | 2001 | 3 |
1220 | 11472271 | Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment. | 2001 Sep | 1 |
1221 | 11490321 | Insulin glargine (Lantus), a new long-acting insulin. | 2001 Aug 6 | 4 |
1222 | 11553198 | Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes. | 2001 Aug | 7 |
1223 | 11577797 | Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus. | 2001 | 12 |
1224 | 11703429 | Recent advances in treatment of youth with Type 1 diabetes: better care through technology. | 2001 Nov | 3 |
1225 | 11712396 | [Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability]. | 2001 Nov | 3 |
1226 | 11727406 | Insulin therapy in type 2 diabetes. | 2001 Dec | 1 |
1227 | 11739448 | Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: comparisons to insulin and IGF-I. | 2001 Dec | 5 |
1228 | 11813930 | Insulin glargine. | 2001 Dec | 13 |
1229 | 11825324 | Insulin glargine: the first clinically useful extended-action insulin analogue. | 2001 Nov | 14 |
1230 | 11910975 | [Present and future of insulin therapy in type 2 diabetic patients]. | 2001 Nov | 1 |
1231 | 12643106 | New aspects of insulin therapy in type 1 and type 2 diabetes. | 2001 Oct | 1 |
1232 | 10730548 | Insulin glargine. | 2000 Feb | 8 |
1233 | 10834411 | Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety. | 2000 May | 2 |
1234 | 10834423 | Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. | 2000 May | 9 |
1235 | 10834424 | Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. | 2000 May | 4 |
1236 | 10841002 | Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. | 2000 Jun | 7 |
1237 | 10866053 | Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. | 2000 Jun | 3 |
1238 | 10932964 | Insulin analogues and management of diabetes mellitus. | 2000 Jun | 2 |
1239 | 10937510 | Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. | 2000 Aug | 5 |
1240 | 10937511 | Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group. | 2000 Aug | 12 |
1241 | 10981882 | Insulin glargine. | 2000 Aug 5 | 1 |
1242 | 11092290 | A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. | 2000 Nov | 9 |
1243 | 11094649 | Insulin glargine. | 2000 Nov 1 | 1 |
1244 | 11118018 | Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. | 2000 Dec | 4 |
1245 | 11130552 | Safety of insulin glargine. | 2000 Dec 9 | 1 |
1246 | 11225967 | Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine. | 2000 Dec | 2 |
1247 | 16049868 | Insulin glargine (Aventis Pharma). | 2000 Sep | 14 |
1248 | 10820651 | Insulin glargine. Glargine, HOE 71GT15, HOE 71GT80, HOE 901. | 1999 Aug | 1 |
1249 | 15992080 | Insulin glargine: the first clinically useful extended-acting insulin in half a century? | 1999 Mar | 9 |